Sunday, September 30, 2012

Company Man At The Top

There are many stories of company outsiders recruited to run a particular company. Nothing is more encouraging to employees when the CEO rose through their ranks. This gives ambitious lower ranked employees hope and inspiration that they too will lead the company one day.

This is exactly what happened to William C. Weldon who worked all his life at Johnson & Johnson (J&J).  One thing about this company is it never hired an outsider to lead it since its founding in 1886 in New Brunswick, New Jersey.  Working his entire career at J&J allowed him to prove himself as an able executive and become the company’s only 6th chairman in 2002.

Weldon was not particularly an academic achiever in school and was more inclined to sports.  He got married while in college studying at Quinnipiac University.  He said marriage made him more serious with his studies. After graduating with a bachelor of science degree in 1971 he got a job in the sales and marketing department at McNeil Pharmaceutical a division of J&J. 

From their Weldon quickly rose through the ranks.  By 1982 he was the manager of J&J’s ICOM Regional Development Center in Southeast Asia. More promotions followed. Weldon became president of Ethicon Endo-Surgery (EES) a newly formed J&J company in 1992. Although coming from a pharmaceutical background Weldon worked hard to make the company a market leader in the medical-instruments market overtaking the number one company by 1996.
This stunning achievement led to more promotions and in 1998 he became worldwide chairman of J&J’s Pharmaceutical Group and became a member of the company’s executive committee. The group was lagging in performance and Weldon was tasked to revive it. He engineered the acquisition of Centocor which had a number of promising drugs. Weldon led another major acquisition in 2001 when J&J acquired Alza Corporation which was known for its transdermal patches. 

Weldon was eventually appointed CEO and chairman of J&J in January 2002. His tenure has been marked by growth and major acquisitions. It has also been rocked by recalls of liquid children’s Tylenol, other medications, and products like contact lenses. He relinquished the CEO post in April 2012 while remaining as chairman.

No comments:

Post a Comment